Stoneridge Investment Partners »

Avita Therapeutics shares owned by Stoneridge Investment Partners

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Stoneridge Investment Partners from 13F filings

Historical chart of Stoneridge Investment Partners investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Stoneridge Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Stoneridge Investment Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $47k 14k 3.43

More positions owned by Stoneridge Investment Partners

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Nike (NKE)
PNC Financial Services (PNC)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Alphabet Inc Class C cs (GOOG)
Target Corporation (TGT)
W.R. Berkley Corporation (WRB)
Zoetis Inc Cl A (ZTS)
Fiserv (FI)
Biogen Idec (BIIB)

View all positions for Stoneridge Investment Partners

Top funds holding Avita Therapeutics

Vanguard Group
BlackRock
Geode Capital Management
State Street Corporation
Northern Trust
Millennium Management
AQR Capital Management
Bridgeway Capital Management
Divisadero Street Capital Management
UBS Group
Goldman Sachs Group
Citadel Advisors
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Charles Schwab Investment Management
Nuveen

View all funds holding Avita Therapeutics